Skip to content

Insider · CIK 0001959742

David Shook

officer

Files at LYEL (Lyell Immunopharma, Inc.). First filing Sep 10, 2026, latest Sep 10, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $6,350 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LYEL: Lyell Immunopharma, Inc.

LYELOct 9, 2026 · close 8.71

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
15Weak
LYELsell
Lyell Immunopharma, Inc.
$6,350
500 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 10, 2026LYEL
Lyell Immunopharma, Inc.
SOpen-market sale
Common Stock
-500$12.70$6,35020,42332 d ago
Jun 9, 2025LYEL
Lyell Immunopharma, Inc.
AGrant or award
Common Stock
+21,900$0.00$021,900Jun 11, 2025
Jun 9, 2025LYEL
Lyell Immunopharma, Inc.
AGrant or award
Option (right to buy)derivative
+43,750$0.00$043,750Jun 11, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David Shook: insider trades and track record | InsiderTell